Osteopontin increases migration and MMP-9 up-regulation via αvβ3 integrin, FAK, ERK, and NF-κB-dependent pathway in human chondrosarcoma cells

Journal of Cellular Physiology

Volumn 221, Issue 1, 2009, Pages 98-108

  Chen, Ying Ju ^a,b   Wei, Ying Ying ^a   Chen, Hsien Te ^c   Fong, Yi Chin ^a,c   Hsu, Chin Jung ^c   Tsai, Chun Hao ^c   Hsu, Horng Chaung ^c   Liu, Shing Hwa ^b   Tang, Chih Hsin ^d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; FOCAL ADHESION KINASE; GELATINASE B; I KAPPA B; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOPONTIN; SCLEROPROTEIN; FOCAL ADHESION KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE; VITRONECTIN RECEPTOR;

ARTICLE; BONE MATRIX; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CHONDROSARCOMA; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INHALATIONAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOMA CELL; CELL MOTION; ENZYMOLOGY; GENETICS; METABOLISM; PATHOLOGY; PROMOTER REGION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UPREGULATION;

CELL LINE, TUMOR; CELL MOVEMENT; CHONDROSARCOMA; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FOCAL ADHESION KINASE 1; HUMANS; INTEGRIN ALPHAVBETA3; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; NF-KAPPA B; OSTEOPONTIN; PROMOTER REGIONS, GENETIC; UP-REGULATION;

EID: 69249235848     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21835     Document Type: Article

References (37)

1. Berend KR, Toth AP, Harrelson JM, Layfield LJ, Hey LA, Scully SP. 1998. Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma. J Bone Joint Surg Am 80:11-17.
2. Brown LF, Berse B, Van, de., Water L, Papadopoulos-Sergiou A, Perruzzi CA, Manseau EJ, Dvorak HF, Senger DR, Papadopoulos A. 1992. Expression and distribution of osteopontin in human tissues: Widespread association with luminal epithelial surfaces. Elevated expression of secreted phosphoprotein I (osteopontin, 2ar) as a consequence of neoplastic transformation. Mol Biol Cell 3:1169-1180.
3. Chang PL, Chambers AF. 2000. Transforming JB6 cells exhibit enhanced integrin-mediated adhesion to osteopontin. J Cell Biochem 78:8-23.
4. Chang MS, Lee WS, Chen BC, Sheu JR, Lin CH. 2004. YC-1-induced cyclooxygenase-2 expression is mediated by cGMP-dependent activations of Ras, phosphoinositide-3-OHkinase, Akt, and nuclear factor-κB in human pulmonary epithelial cells. Mol Pharmacol 66:561-571.
5. Cheng JC, Chou CH, Kuo ML, Hsieh CY. 2006. Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway. Oncogene 53:7009-7018. (Pubitemid 44722069)
6. Crouch DH, Fincham VJ, Frame MC. 1996. Targeted proteolysis of the focal adhesion kinase pp125 FAK during c-MYC-induced apoptosis is suppressed by integrin signalling. Oncogene 12:2689-2696.
7. Denhardt DT, Chambers AF. 1994. Overcoming obstacles to metastasis - Defenses against host defenses: Osteopontin (OPN) as a shield against attack by cytotoxic host cells. J Cell Biochem 56:48-51.
8. Denhardt DT, Noda M. 1998. Osteopontin expression and function: Role in bone remodeling. J Cell Biochem 72:92-102. (Pubitemid 29028730)
9. Egeblad M, Werb Z. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161-174. (Pubitemid 37328786)
10. Fong YC, Yang WH, Hsu SF, Hsu HC, Tseng KF, Hsu CJ, Lee CY, Scully SP. 2007. 2- Methoxyestradiol induces apoptosis and cell cycle arrest in human chondrosarcoma cells. J Orthop Res 25:1106-1114. (Pubitemid 47233087)
11. Fong YC, Liu SC, Huang CY, Li TM, Hsu SF, Kao ST, Tsai FJ, Chen WC, Chen CY, Tang CH. 2009. Osteopontin increases lung cancer cells migration via activation of the alphavbeta3 integrin/FAK/Akt and NF-kappaB-dependent pathway. Lung Cancer 64: 263-270.
12. Giancotti FG, Ruoslahti E. 1999. Integrin signaling. Science 285:1028-1032.
13. Hadden HL, Henke CA. 2000. Induction of lung fibroblast apoptosis by soluble fibronectin peptides. Am J Respir Crit Care Med 162:1553-1560.
14. Hayashi C, Rittling S, Hayata T, Amagasa T, Denhardt D, Ezura Y, Nakashima K, Noda M. 2007. Serum osteopontin, an enhancer of tumor metastasis to bone, promotes B16 melanoma cell migration. J Cell Biochem 101:979-986. (Pubitemid 47040877)
15. Hsu CP, Shen GH, Ko JL. 2006. Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer. Lung Cancer 52:349-357. (Pubitemid 43674546)
16. Humphries MJ. 2000. Integrin structure. Biochem Soc Trans 28:311-339.
17. Hynes RO. 2002. Integrins: Bidirectional, allosteric signaling machines. Cell 110:673-687.
18. Inoue J, Gohda J, Akiyama T, Semba K. 2007. NF-kappaB activation in development and progression of cancer. Cancer Sci 98:268-274. (Pubitemid 46195594)
19. Kapur S, Baylink DJ, Lau KH. 2003. Fluid flow shear stress stimulates human osteoblast proliferation and differentiation through multiple interacting and competing signal transduction pathways. Bone 32:241-251. (Pubitemid 36349527)
20. Kerkelä E, Saarialho-Kere U. 2003. Matrix metalloproteinases in tumor progression: Focus on basal and squamous cell skin cancer. Exp Dermatol 12:109-125. (Pubitemid 36934696)
21. Li JJ, Han M, Wen JK, Li AY. 2007. Osteopontin stimulates vascular smooth muscle cell migration by inducingFAKphosphorylation and ILK dephosphorylation. Biochem. Biophys. Res Commun 356:13-19.
22. Miranti CK, Brugge JS. 2002. Sensing the environment: A historical perspective on integrin signal transduction. Nat Cell Biol 4:E83-E90.
23. Ohbayashi H. 2002. Matrix metalloproteinases in lung diseases. Curr Protein Pept Sci 3:409-421.
24. Pfaff M, Tangemann K, Muller B, Gurrath M, Muller G, Kessler H, Timpl R, Engel J. 1994. Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins. J Biol Chem 269:20233-20238. (Pubitemid 24260416)
25. Rangaswami H, Kundu GC. 2007. Osteopontin stimulates melanoma growth and lung metastasis through NIK/MEKK1-dependent MMP-9 activation pathways. Oncol Rep 18:909-915.
26. Rao JS, Gondi C, Chetty C, Chittivelu S, Joseph PA, Lakka SS. 2005. Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells. Mol Cancer Ther 4:1399-1408.
27. Senger DR, Perruzzi CA, Papadopoulos A. 1989. Elevated expression of secreted phosphoprotein I (osteopontin, 2ar) as a consequence of neoplastic transformation. Anticancer Res 9:1291-1299. (Pubitemid 19277158)
28. Shannon KE, Keene JL, Settle SL. 2004. Anti-metastatic properties of RGD-peptidomimetic agents S137 and S247. Clin Exp Metastasis 21:129-138.
29. Springfield M. 1998. Surgery for bone and soft-tissue tumors. Philadelphia: Lippincott-Raven Publishers.
30. Tang CH, Tan TW, Fu WM, Yang RS. 2008. Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis. Carcinogenesis 29:35-43.
31. Terek RM, Schwartz GK, Devaney K, Glantz L, Mak S, Healey JH. 1998. Chemotherapy and P-glycoprotein expression in chondrosarcoma. J Orthop Res 16:585-590.
32. Wai PY, Kuo PC. 2008. Osteopontin: Regulation in tumor metastasis. Cancer Metastasis Rev 27:103-118.
33. Yeh YY, Chiao CC, Kuo WY, Hsiao YC, Chen YJ, Wei YY, Lai TH, Fong YC, Tang CH. 2008. TGF-beta1 increases motility and alphavbeta3 integrin up-regulation via PI3K, Akt and NFkappaB- dependent pathway in human chondrosarcoma cells. Biochem Pharmacol 75: 1292-1301.
34. Yuan J, Dutton CM, Scully SP. 2005. RNAi mediated MMP-1 silencing inhibits human chondrosarcoma invasion. J Orthop Res 23: 1467-1474. (Pubitemid 41554684)
35. Yeh YY, Chiao CC, Kuo WY, Hsiao YC, Chen YJ, Wei YY, Lai TH, Fong YC, Tang CH. 2008. TGF-beta1 increases motility and alphavbeta3 integrin up-regulation via PI3K, Akt and NFkappaB- dependent pathway in human chondrosarcoma cells. Biochem Pharmacol 75:1292-1301.
36. Yuan J, Dutton CM, Scully SP. 2005. RNAi mediated MMP-1 silencing inhibits human chondrosarcoma invasion. J Orthop Res 23:1467-1474. (Pubitemid 41554684)
37. ZoharR, SuzukiN, Suzuki K, Arora P,Glogauer M, McCulloch CA, Sodek J. 2002. Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration. J Cell Physiol 184:118-130. (Pubitemid 30349635)